Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Alcami Completes Expansion of cGMP Biostorage Facility in Amherst, NH | Contract Pharma

What are you searching for?

Sign in
Breaking News

Alcami Completes Expansion of cGMP Biostorage Facility in Amherst, NH

Creates a total of 160,000 ft² of ambient cGMP biostorage capacity with 21,000 pallet locations.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Alcami Corp., a CDMO, has completed the Phase III expansion of its cGMP biostorage facility in Amherst, NH, creating a total of 160,000 ft² of ambient cGMP biostorage capacity with 21,000 pallet locations. It is now fully operational to support a variety of cGMP client storage needs.
 
“The successful on-time completion of this expansion project enhances Alcami’s ability to support our biopharma clients’ increasing demand for secure and reliable cGMP storage needs,” commented Timothy Compton, Chief Business Officer at Alcami.
 
Alcami has also added nearly 10,000 ft³ of -20 ˚C cold storage capacity and over 12,000 ft³ of ICH stability storage in Massachusetts.
 
“We continue to expand across all of our locations to provide our customers with streamlined solutions in support of their products and the patients they serve,” said Mr. Compton.

Alcami now offers 440,000 ft² of biostorage capacity across four U.S. locations in New Hampshire and Massachusetts, with a fifth site coming online later this year in North Carolina. Alcami’s biostorage service offering provides high-quality, secure cGMP storage capacity for a wide range of cGMP temperature storage conditions from ≤-135˚C to 70˚C, including all ICH stability conditions for vaccines, biopharma therapies, cell banks, tissues, pharmaceutical compounds, raw materials, components, and medical devices.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics